LuciUpa (Upadacitinib) 15mg | Generic JAK1 Inhibitor | Lucius Pharmaceuticals (Lao) Co., Ltd. | GLT

Generic Information: LuciUpa (Upadacitinib) — Lucius

LuciUpa is a generic upadacitinib produced by Lucius Pharmaceuticals (Lao) Co., Ltd., a maker known across Southeast Asia for affordable oncology and specialty generics. It delivers the selective JAK1 inhibitor as a 15 mg tablet in a 30-count pack — a full month at the standard once-daily dose, positioned as a budget-friendly option for patients managing a chronic autoimmune condition.

What Is LuciUpa (Upadacitinib) Used For?

LuciUpa is used for immune-mediated inflammatory diseases:

• Rheumatoid arthritis — moderate to severe active disease in adults with an inadequate response to TNF inhibitors.
• Atopic dermatitis — moderate to severe eczema in adults and adolescents 12 years and older.
• Psoriatic arthritis — active disease in adults with an inadequate response to DMARDs.
• Ulcerative colitis and Crohn's disease — moderate to severe active disease in adults.

How Does LuciUpa (Upadacitinib) Work?

LuciUpa's active ingredient, upadacitinib, blocks the JAK1 enzyme that relays inflammatory signals inside immune cells. Cutting that relay reduces the inflammation behind rheumatoid arthritis, eczema and related conditions. As a generic of RINVOQ, it acts through the same mechanism.

Indications

• Moderate to severe active rheumatoid arthritis in adults
• Active psoriatic arthritis in adults
• Moderate to severe atopic dermatitis in adults and adolescents 12+ years
• Moderate to severe active ulcerative colitis and Crohn's disease in adults

Dosage & Administration

LuciUpa is taken as one 15 mg tablet once daily, with or without food; the 30-count pack covers a month. For bowel disease a 45 mg daily induction dose is used before stepping down to maintenance. Swallow the tablet whole and follow your physician's instructions.

Side Effects

Common side effects are upper respiratory tract infections, nausea, cough and fever. Serious risks include serious infections, shingles, blood clots, major cardiovascular events and certain cancers. A boxed warning covers these, and a tuberculosis test is advised before treatment.

Storage & Handling

Store LuciUpa in the original pack at room temperature, protected from moisture and light, and out of reach of children.

Why Choose LuciUpa (Generic Upadacitinib) by Lucius?

• One-month pack — 30 tablets at the standard dose, aligned to a monthly routine.
• Lower-cost generic — the same upadacitinib active ingredient as RINVOQ at a reduced price.
• Lucius manufacturing — produced by Lucius Pharmaceuticals (Lao) Co., Ltd. to GMP standards.
• GLT supply — GIVE LIFE TIME LIMITED ships batch-traceable LuciUpa with documentation worldwide.

How to Order LuciUpa (Upadacitinib) from GLT?

1. Contact GLT on WhatsApp +86 15234153837 or email [email protected] with the quantity required.
2. Receive a formal quotation, payment instructions and delivery estimate.
3. Pay via our secured channel (Hao Yi Lian / 好易联).
4. Goods are dispatched with batch records and tracked until delivery.

We serve licensed institutions and individual patients; a valid prescription may be requested before dispatch.

FAQ

1. Is LuciUpa a generic of upadacitinib?

Yes. LuciUpa is a generic upadacitinib made by Lucius Pharmaceuticals in Laos, containing the same active ingredient as RINVOQ.

2. What is the price of LuciUpa (generic upadacitinib)?

As a generic it is priced below the originator. Contact GLT for a quotation based on your quantity and destination.

3. How many tablets are in a pack of LuciUpa?

LuciUpa is supplied as 15 mg tablets in a 30-count pack.

4. Where can I buy generic upadacitinib?

You can order LuciUpa and other generic upadacitinib brands through GLT via WhatsApp +86 15234153837 or email [email protected].

5. Does LuciUpa require a prescription?

Yes, upadacitinib is a prescription medicine, and a valid prescription may be requested before dispatch.